Loading...

The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer

Over 30% of ERα breast cancer patients develop relapses and progress to metastatic disease despite treatment with endocrine therapies. The pioneer factor PBX1 translates epigenetic cues and mediates estrogen induced ERα binding. Here we demonstrate that PBX1 plays a central role in regulating the ER...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Magnani, Luca, Patten, Darren K., Nguyen, Van T.M., Hong, Sung-Pil, Steel, Jennifer H., Patel, Naina, Lombardo, Ylenia, Faronato, Monica, Gomes, Ana R., Woodley, Laura, Page, Karen, Guttery, David, Primrose, Lindsay, Garcia, Daniel Fernandez, Shaw, Jacqui, Viola, Patrizia, Green, Andrew, Nolan, Christopher, Ellis, Ian O., Rakha, Emad A., Shousha, Sami, Lam, Eric W.-F., Győrffy, Balázs, Lupien, Mathieu, Coombes, R. Charles
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673133/
https://ncbi.nlm.nih.gov/pubmed/26215677
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!